The effect of dietary glycine on the hepatic tumor promoting activity of polychlorinated biphenyls (PCBs) in rats.
Polychlorinated biphenyls (PCBs) are ubiquitious lipophilic environmental pollutants. Some of the PCB congeners and mixtures of congeners have tumor promoting activity in rat liver. The mechanism of their activity is not fully understood and is likely to be multifactorial. The aim of this study was to investigate if the resident liver macrophages, Kupffer cells, are important in the promoting activity of PCBs. The hypothesis of this study was that the inhibition of Kupffer cell activity would inhibit hepatic tumor promotion by PCBs in rats. To test our hypothesis, we studied the effects of Kupffer cell inhibition by dietary glycine (an inhibitor of Kupffer cell secretory activity) in a rat two-stage hepatocarcinogenesis model using 2,2',4,4',5,5'-hexachlorobiphenyl (PCB-153, a non-dioxin-like PCB) or 3,3',4,4'-tetrachlorobiphenyl (PCB-77, a dioxin-like PCB) as promoters. Diethylnitrosamine (DEN, 150 mg/kg) was administered to female Sprague-Dawley rats, which were then placed on an unrefined diet containing 5% glycine (or casein as nitrogen control) starting two weeks after DEN administration. On the third day after starting the diets, rats received PCB-77 (300 micromol/kg), PCB-153 (300 micromol/kg), or corn oil by i.p. injection. The rats received a total of 4 PCB injections, administered every 14 days. The rats were euthanized on the 10th day after the last PCB injection, and the formation of altered hepatic foci expressing placental glutathione S-transferase (PGST) and the rate of DNA synthesis in these foci and in the normal liver tissue were determined. Glycine did not significantly affect foci number or volume. PCB-153 did not significantly increase the focal volume, but increased the number of foci per liver, but only in the rats not fed glycine; PCB-77 increased both the foci number and their volume in both glycine-fed and control rats. Glycine did not alter the PCB content of the liver, but did increase the activity of 7-benzyloxyresorufin O-dealkylase (BROD) in liver microsomes from PCB-153 treated rats. However, glycine did not affect the induction of ethoxyresorufin O-dealkylase activity by PCB-77 in liver microsomes. Glycine diminished hepatocyte proliferation in PGST-positive foci, but not in normal tissue. Overall these results do not support the hypothesis that dietary glycine inhibits the promoting activities of PCBs. The observations that PCB-153 increased the number of foci per liver in control rats but not glycine-fed rats and that dietary glycine reduced cell proliferation in PGST-positive foci, however, do not allow us to completely rule out a role for dietary glycine. But the data overall indicate that Kupffer cells likely do not contribute to the tumor promoting activities of PCB-77 and PCB-153.
Bunaciu
Rodica Petruta
RP
Graduate Center for Nutritional Sciences,University of Kentucky, Lexington, KY 40506-0054, United States.
Tharappel
Job C
JC
Lehmler
Hans-Joachim
HJ
Kania-Korwel
Izabela
I
Robertson
Larry W
LW
Srinivasan
Cidambi
C
Spear
Brett T
BT
Glauert
Howard P
HP
D000284:Administration, Oral; D000477:Alkylating Agents / Q000008:administration & dosage / Q000633:toxicity; D000818:Animals; D001835:Body Weight / Q000187:drug effects; D002274:Carcinogens, Environmental / Q000008:administration & dosage / Q000633:toxicity; D049109:Cell Proliferation / Q000187:drug effects; D019363:Cytochrome P-450 CYP1A1 / Q000378:metabolism; D019362:Cytochrome P-450 CYP2B1 / Q000378:metabolism; D004032:Diet; D004052:Diethylnitrosamine / Q000008:administration & dosage / Q000633:toxicity; D005260:Female; D005982:Glutathione Transferase / Q000378:metabolism; D005998:Glycine / Q000008:administration & dosage* / Q000494:pharmacology; D022781:Hepatocytes / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D007150:Immunohistochemistry; D007274:Injections, Intraperitoneal; D008099:Liver / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D009929:Organ Size / Q000187:drug effects; D011078:Polychlorinated Biphenyls / Q000008:administration & dosage / Q000633:toxicity*; D011230:Precancerous Conditions / Q000378:metabolism / Q000473:pathology; D051381:Rats; D017207:Rats, Sprague-Dawley
D000477:Alkylating Agents; D002274:Carcinogens, Environmental; D004052:Diethylnitrosamine; D011078:Polychlorinated Biphenyls; D019363:Cytochrome P-450 CYP1A1; D019362:Cytochrome P-450 CYP2B1; D005982:Glutathione Transferase; D005998:Glycine; C028451:3,4,3',4'-tetrachlorobiphenyl; C014024:2,4,5,2',4',5'-hexachlorobiphenyl
Eur J Pharmacol. 1999 Feb 26;368(1):75-87
10096772
Chemosphere. 2001 Oct;45(2):137-43
11572605
Eur J Epidemiol. 2004;19(8):793-801
15469037
Hepatology. 1997 Dec;26(6):1530-7
9397994
J Food Prot. 2004 Aug;67(8):1787-91
15330552
Carcinogenesis. 1995 Feb;16(2):393-8
7859372
Cancer Res. 1982 Feb;42(2):465-72
6120037
Drug Metab Dispos. 1974 Nov-Dec;2(6):583-8
4155680
Toxicol Appl Pharmacol. 2002 Mar 15;179(3):172-84
11906247
Am J Physiol. 1996 Jul;271(1 Pt 1):G97-103
8760112
Bull Mem Acad R Med Belg. 2004;159(5-6):358-66
15693545
Environ Res. 2003 Oct;93(2):167-76
12963401
Drug Metab Dispos. 1990 Jul-Aug;18(4):467-70
1976069
Transpl Int. 2005 Sep;18(9):1079-89
16101730
Environ Pollut. 1994;84(1):69-77
15091726
Drug Metab Dispos. 1992 May-Jun;20(3):407-12
1355716
Fundam Appl Toxicol. 1982 Mar-Apr;2(2):55-66
6764428
Pharmacol Ther. 1997;73(2):121-46
9131721
Chem Res Toxicol. 1997 Oct;10(10):1198-204
9348444
Eur J Cancer Prev. 2003 Aug;12(4):251-5
12883375
J Nutr. 2005 Feb;135(2):283-6
15671227
Comput Methods Programs Biomed. 1998 Apr;56(1):49-63
9617527
Mol Carcinog. 2003 Aug;37(4):171-80
12891626
Arch Environ Contam Toxicol. 1997 Jul;33(1):104-8
9216878
J Occup Environ Med. 2003 Mar;45(3):271-82
12661184
Carcinogenesis. 1999 Nov;20(11):2075-81
10545408
Environ Sci Technol. 2005 May 15;39(10):3513-20
15954224
Sci Total Environ. 1994 Jun 13;149(1-2):113-9
8029709
Princess Takamatsu Symp. 1987;18:61-6
3147283
Toxicol Appl Pharmacol. 2003 Jan 1;186(1):55-62
12583993
Carcinogenesis. 1997 Aug;18(8):1453-6
9276615
Toxicol Appl Pharmacol. 1993 Apr;119(2):275-9
8480336
Chirality. 2007 Jan;19(1):56-66
17089340
Cell Tissue Kinet. 1986 Mar;19(2):179-82
3698075
J Biol Chem. 2004 May 7;279(19):19383-6
15023997
Toxicol Sci. 2001 Jul;62(1):36-45
11399791
Toxicol Sci. 2002 Mar;66(1):54-61
11861972
Alcohol Clin Exp Res. 2005 Nov;29(11 Suppl):162S-5S
16344603
Am J Epidemiol. 1992 Aug 15;136(4):389-98
1415158
Carcinogenesis. 1999 Jan;20(1):27-33
9934846
Biochem Pharmacol. 1985 Oct 15;34(20):3735-9
4052112
J Natl Cancer Inst. 1986 Apr;76(4):751-67
2870209
Mutat Res. 2000 Mar 17;448(2):179-92
10725471
Carcinogenesis. 1999 Nov;20(11):2095-100
10545411
Prog Clin Biol Res. 1984;137:19-30
6425851
Environ Health Perspect. 1985 Feb;59:5-10
3921364
Anal Bioanal Chem. 2004 Dec;380(7-8):924-9
15700170
Antioxid Redox Signal. 2000 Fall;2(3):607-21
11229371
Eur J Pharmacol. 1995 Mar 16;292(3-4):257-63
7796864
Pediatr Res. 1998 Aug;44(2):222-5
9702918